Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience.

MLA

Schreib, Katharina M., et al. “Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience.” Pharmaceutics, vol. 16, no. 1, Jan. 2024, p. 13. EBSCOhost, https://doi.org/10.3390/pharmaceutics16010013.

APA

Schreib, K. M., Bräm, D. S., Zeilhofer, U. B., Müller, D., Güngör, T., Krämer, S. D., & Hauri-Hohl, M. M. (2024). Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience. Pharmaceutics, 16(1), 13. https://doi.org/10.3390/pharmaceutics16010013

Chicago

Schreib, Katharina M., Dominic S. Bräm, Ulrike Barbara Zeilhofer, Daniel Müller, Tayfun Güngör, Stefanie D. Krämer, and Mathias M. Hauri-Hohl. 2024. “Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience.” Pharmaceutics 16 (1): 13. doi:10.3390/pharmaceutics16010013.